STOCKWELL GROUP PRACTICE
107 STOCKWELL ROAD, LONDON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 5 | 6 | 83.3% | |
| HF 4 | 2011 | 7 | 8 | 87.5% | |
| HF 4 | 2012 | 8 | 9 | 88.9% | |
| HF 4 | 2013 | 9 | 9 | 100.0% | |
| HF004 | 2014 | 30 | 32 | 93.8% | |
| HF004 | 2015 | 27 | 28 | 96.4% | |
| HF004 | 2016 | 24 | 26 | 92.3% | |
| HF004 | 2017 | 23 | 25 | 92.0% | |
| HF004 | 2018 | 23 | 24 | 95.8% | |
| HF004 | 2019 | 24 | 24 | 100.0% | |
| HF004 | 2020 | 23 | 26 | 88.5% | |
| HF006 | 2021 | 22 | 24 | 91.7% | |
| HF006 | 2022 | 26 | 27 | 96.3% | |
| HF006 | 2023 | 24 | 26 | 92.3% |
